Trial Profile
Effectiveness of Vaccination with Conjugated Pneumococcal Vaccine in Patients with Chronic Obstructive Pulmonary Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Jul 2018
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine conjugate PPV 23 (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 05 Jul 2018 New trial record
- 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society